IRWD
Ironwood Pharmaceuticals, Inc.
A Boston-based biotechnology company that develops and sells medicines for digestive and rare diseases, best known for Linzess, a prescription treatment for chronic constipation and irritable bowel syndrome. It began in 1998 as Microbia, founded by postdocs from a Whitehead Institute lab, and renamed itself Ironwood in 2008 after the long-lived desert tree that shelters other plants — a nod to endurance. Its flagship drug linaclotide was discovered by those same early researchers.
CUSIP: 46333X108HealthcareUS1 holder
Total Value
$23.29M
Total Shares
2.10M
Net Share Change
+2.10M
Activity
1 buying
Investor
Value
Shares
Weight
Change
